NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine
Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and
symptoms of dry eye after a 3 month treatment period.